In older people going through induction therapy with hypomethylating agent + venetoclax, the median reaction time ranges from one.This results in insufficient creation of pink blood cells and platelets. The modern consensus tips founded by the European LeukemiaNET (ELN) in 2022 have emphasised molecular characterization and risk stratification for